nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—PTGER3—polycystic ovary syndrome	0.442	0.68	CbGaD
Dinoprostone—CYP11A1—polycystic ovary syndrome	0.137	0.211	CbGaD
Dinoprostone—CYP19A1—polycystic ovary syndrome	0.0708	0.109	CbGaD
Dinoprostone—SLC22A2—Metformin—polycystic ovary syndrome	0.0584	0.535	CbGbCtD
Dinoprostone—SLC22A1—Metformin—polycystic ovary syndrome	0.0508	0.465	CbGbCtD
Dinoprostone—PTGFR—corpus luteum—polycystic ovary syndrome	0.0084	0.0846	CbGeAlD
Dinoprostone—CYP19A1—follicular fluid—polycystic ovary syndrome	0.00722	0.0727	CbGeAlD
Dinoprostone—PTGFR—ovarian follicle—polycystic ovary syndrome	0.00657	0.0662	CbGeAlD
Dinoprostone—CYP11A1—corpus luteum—polycystic ovary syndrome	0.00641	0.0645	CbGeAlD
Dinoprostone—CYP11A1—ovarian follicle—polycystic ovary syndrome	0.00501	0.0505	CbGeAlD
Dinoprostone—CYP19A1—corpus luteum—polycystic ovary syndrome	0.00416	0.0419	CbGeAlD
Dinoprostone—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.00325	0.0328	CbGeAlD
Dinoprostone—HPGDS—urine—polycystic ovary syndrome	0.00297	0.0299	CbGeAlD
Dinoprostone—Misoprostol—PTGER3—polycystic ovary syndrome	0.00274	0.45	CrCbGaD
Dinoprostone—Bimatoprost—PTGER3—polycystic ovary syndrome	0.00165	0.271	CrCbGaD
Dinoprostone—SLC22A8—urine—polycystic ovary syndrome	0.00133	0.0134	CbGeAlD
Dinoprostone—SLC51B—endometrium—polycystic ovary syndrome	0.00132	0.0133	CbGeAlD
Dinoprostone—PTGER2—adrenal cortex—polycystic ovary syndrome	0.0011	0.011	CbGeAlD
Dinoprostone—SLC51B—adrenal gland—polycystic ovary syndrome	0.00106	0.0107	CbGeAlD
Dinoprostone—SLC51A—adrenal cortex—polycystic ovary syndrome	0.00106	0.0106	CbGeAlD
Dinoprostone—Dinoprost Tromethamine—PTGER3—polycystic ovary syndrome	0.001	0.164	CrCbGaD
Dinoprostone—PTGER2—endometrium—polycystic ovary syndrome	0.000979	0.00986	CbGeAlD
Dinoprostone—HPGDS—embryo—polycystic ovary syndrome	0.000961	0.00968	CbGeAlD
Dinoprostone—PTGER4—endometrium—polycystic ovary syndrome	0.000961	0.00968	CbGeAlD
Dinoprostone—SLC51B—endocrine gland—polycystic ovary syndrome	0.000923	0.0093	CbGeAlD
Dinoprostone—CYP1A2—urine—polycystic ovary syndrome	0.000912	0.00919	CbGeAlD
Dinoprostone—PTGER2—uterus—polycystic ovary syndrome	0.000902	0.00908	CbGeAlD
Dinoprostone—PTGER4—uterus—polycystic ovary syndrome	0.000885	0.00892	CbGeAlD
Dinoprostone—PTGER2—adipose tissue—polycystic ovary syndrome	0.000882	0.00888	CbGeAlD
Dinoprostone—PTGER4—adipose tissue—polycystic ovary syndrome	0.000866	0.00872	CbGeAlD
Dinoprostone—PTGER2—adrenal gland—polycystic ovary syndrome	0.000791	0.00797	CbGeAlD
Dinoprostone—PTGER4—adrenal gland—polycystic ovary syndrome	0.000777	0.00782	CbGeAlD
Dinoprostone—SLC51A—adrenal gland—polycystic ovary syndrome	0.000763	0.00768	CbGeAlD
Dinoprostone—PTGER3—uterus—polycystic ovary syndrome	0.00075	0.00755	CbGeAlD
Dinoprostone—PTGER2—female gonad—polycystic ovary syndrome	0.000738	0.00743	CbGeAlD
Dinoprostone—PTGER2—vagina—polycystic ovary syndrome	0.000733	0.00738	CbGeAlD
Dinoprostone—PTGER3—adipose tissue—polycystic ovary syndrome	0.000733	0.00738	CbGeAlD
Dinoprostone—PTGER4—female gonad—polycystic ovary syndrome	0.000724	0.00729	CbGeAlD
Dinoprostone—SLC51A—vagina—polycystic ovary syndrome	0.000707	0.00712	CbGeAlD
Dinoprostone—HPGDS—endometrium—polycystic ovary syndrome	0.000703	0.00708	CbGeAlD
Dinoprostone—PTGER1—female gonad—polycystic ovary syndrome	0.000699	0.00704	CbGeAlD
Dinoprostone—Bimatoprost—AKR1C3—polycystic ovary syndrome	0.000694	0.114	CrCbGaD
Dinoprostone—PTGER4—endocrine gland—polycystic ovary syndrome	0.000673	0.00678	CbGeAlD
Dinoprostone—SLC51A—endocrine gland—polycystic ovary syndrome	0.000662	0.00666	CbGeAlD
Dinoprostone—PTGER3—adrenal gland—polycystic ovary syndrome	0.000658	0.00662	CbGeAlD
Dinoprostone—PTGER1—endocrine gland—polycystic ovary syndrome	0.00065	0.00655	CbGeAlD
Dinoprostone—HPGDS—uterus—polycystic ovary syndrome	0.000648	0.00653	CbGeAlD
Dinoprostone—HPGDS—adipose tissue—polycystic ovary syndrome	0.000634	0.00638	CbGeAlD
Dinoprostone—PTGER3—female gonad—polycystic ovary syndrome	0.000613	0.00618	CbGeAlD
Dinoprostone—PTGFR—uterus—polycystic ovary syndrome	0.000599	0.00604	CbGeAlD
Dinoprostone—PTGFR—adipose tissue—polycystic ovary syndrome	0.000586	0.0059	CbGeAlD
Dinoprostone—PTGER3—endocrine gland—polycystic ovary syndrome	0.00057	0.00574	CbGeAlD
Dinoprostone—HPGDS—adrenal gland—polycystic ovary syndrome	0.000568	0.00572	CbGeAlD
Dinoprostone—SLCO2A1—adrenal cortex—polycystic ovary syndrome	0.000561	0.00565	CbGeAlD
Dinoprostone—CYP11A1—adrenal cortex—polycystic ovary syndrome	0.000555	0.00559	CbGeAlD
Dinoprostone—HPGDS—female gonad—polycystic ovary syndrome	0.00053	0.00534	CbGeAlD
Dinoprostone—HPGDS—vagina—polycystic ovary syndrome	0.000527	0.00531	CbGeAlD
Dinoprostone—PTGFR—adrenal gland—polycystic ovary syndrome	0.000526	0.0053	CbGeAlD
Dinoprostone—SLCO1C1—pituitary gland—polycystic ovary syndrome	0.00052	0.00524	CbGeAlD
Dinoprostone—SLCO1C1—adipose tissue—polycystic ovary syndrome	0.000518	0.00522	CbGeAlD
Dinoprostone—PTGIR—adipose tissue—polycystic ovary syndrome	0.000517	0.0052	CbGeAlD
Dinoprostone—SLCO4A1—adrenal cortex—polycystic ovary syndrome	0.000516	0.0052	CbGeAlD
Dinoprostone—SLCO2A1—endometrium—polycystic ovary syndrome	0.000501	0.00505	CbGeAlD
Dinoprostone—HPGDS—endocrine gland—polycystic ovary syndrome	0.000493	0.00496	CbGeAlD
Dinoprostone—PTGFR—female gonad—polycystic ovary syndrome	0.00049	0.00494	CbGeAlD
Dinoprostone—PTGIR—adrenal gland—polycystic ovary syndrome	0.000463	0.00467	CbGeAlD
Dinoprostone—SLCO2A1—uterus—polycystic ovary syndrome	0.000462	0.00465	CbGeAlD
Dinoprostone—SLCO4A1—endometrium—polycystic ovary syndrome	0.000461	0.00464	CbGeAlD
Dinoprostone—SLCO3A1—pituitary gland—polycystic ovary syndrome	0.000458	0.00461	CbGeAlD
Dinoprostone—PTGFR—endocrine gland—polycystic ovary syndrome	0.000456	0.00459	CbGeAlD
Dinoprostone—SLCO3A1—adipose tissue—polycystic ovary syndrome	0.000456	0.00459	CbGeAlD
Dinoprostone—SLCO2A1—pituitary gland—polycystic ovary syndrome	0.000453	0.00457	CbGeAlD
Dinoprostone—SLCO2A1—adipose tissue—polycystic ovary syndrome	0.000452	0.00455	CbGeAlD
Dinoprostone—CYP11A1—adipose tissue—polycystic ovary syndrome	0.000447	0.0045	CbGeAlD
Dinoprostone—PTGIR—female gonad—polycystic ovary syndrome	0.000432	0.00435	CbGeAlD
Dinoprostone—SLCO4A1—pituitary gland—polycystic ovary syndrome	0.000417	0.0042	CbGeAlD
Dinoprostone—SLCO4A1—adipose tissue—polycystic ovary syndrome	0.000415	0.00418	CbGeAlD
Dinoprostone—ABCC5—pituitary gland—polycystic ovary syndrome	0.000415	0.00418	CbGeAlD
Dinoprostone—ABCC5—adipose tissue—polycystic ovary syndrome	0.000413	0.00416	CbGeAlD
Dinoprostone—SLCO3A1—adrenal gland—polycystic ovary syndrome	0.000409	0.00412	CbGeAlD
Dinoprostone—SLCO2A1—adrenal gland—polycystic ovary syndrome	0.000405	0.00408	CbGeAlD
Dinoprostone—SLCO1C1—endocrine gland—polycystic ovary syndrome	0.000403	0.00406	CbGeAlD
Dinoprostone—PTGIR—endocrine gland—polycystic ovary syndrome	0.000402	0.00405	CbGeAlD
Dinoprostone—CYP11A1—adrenal gland—polycystic ovary syndrome	0.000401	0.00404	CbGeAlD
Dinoprostone—SLC22A11—endocrine gland—polycystic ovary syndrome	0.000392	0.00394	CbGeAlD
Dinoprostone—SLC22A7—endocrine gland—polycystic ovary syndrome	0.000382	0.00385	CbGeAlD
Dinoprostone—SLCO3A1—female gonad—polycystic ovary syndrome	0.000381	0.00384	CbGeAlD
Dinoprostone—SLCO3A1—vagina—polycystic ovary syndrome	0.000379	0.00382	CbGeAlD
Dinoprostone—SLCO2A1—female gonad—polycystic ovary syndrome	0.000378	0.0038	CbGeAlD
Dinoprostone—SLCO2A1—vagina—polycystic ovary syndrome	0.000375	0.00378	CbGeAlD
Dinoprostone—CYP11A1—female gonad—polycystic ovary syndrome	0.000374	0.00376	CbGeAlD
Dinoprostone—SLCO4A1—adrenal gland—polycystic ovary syndrome	0.000373	0.00375	CbGeAlD
Dinoprostone—ABCC5—adrenal gland—polycystic ovary syndrome	0.00037	0.00373	CbGeAlD
Dinoprostone—SLCO3A1—endocrine gland—polycystic ovary syndrome	0.000355	0.00357	CbGeAlD
Dinoprostone—SLCO2A1—endocrine gland—polycystic ovary syndrome	0.000351	0.00354	CbGeAlD
Dinoprostone—CYP11A1—endocrine gland—polycystic ovary syndrome	0.000348	0.0035	CbGeAlD
Dinoprostone—ABCC5—female gonad—polycystic ovary syndrome	0.000345	0.00348	CbGeAlD
Dinoprostone—SLCO4A1—vagina—polycystic ovary syndrome	0.000345	0.00348	CbGeAlD
Dinoprostone—ABCC5—vagina—polycystic ovary syndrome	0.000343	0.00346	CbGeAlD
Dinoprostone—SLCO2B1—uterus—polycystic ovary syndrome	0.00033	0.00333	CbGeAlD
Dinoprostone—SLCO2B1—adipose tissue—polycystic ovary syndrome	0.000323	0.00326	CbGeAlD
Dinoprostone—SLCO4A1—endocrine gland—polycystic ovary syndrome	0.000323	0.00325	CbGeAlD
Dinoprostone—CYP19A1—endometrium—polycystic ovary syndrome	0.000322	0.00324	CbGeAlD
Dinoprostone—SLC22A1—adipose tissue—polycystic ovary syndrome	0.000309	0.00311	CbGeAlD
Dinoprostone—CYP19A1—uterus—polycystic ovary syndrome	0.000297	0.00299	CbGeAlD
Dinoprostone—ABCC4—uterus—polycystic ovary syndrome	0.000293	0.00295	CbGeAlD
Dinoprostone—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00029	0.00292	CbGeAlD
Dinoprostone—SLCO2B1—adrenal gland—polycystic ovary syndrome	0.00029	0.00292	CbGeAlD
Dinoprostone—ABCC4—adipose tissue—polycystic ovary syndrome	0.000286	0.00288	CbGeAlD
Dinoprostone—SLCO1B1—endocrine gland—polycystic ovary syndrome	0.000284	0.00286	CbGeAlD
Dinoprostone—SLCO2B1—female gonad—polycystic ovary syndrome	0.00027	0.00272	CbGeAlD
Dinoprostone—CYP19A1—adrenal gland—polycystic ovary syndrome	0.00026	0.00262	CbGeAlD
Dinoprostone—SLC22A1—vagina—polycystic ovary syndrome	0.000257	0.00259	CbGeAlD
Dinoprostone—ABCC4—adrenal gland—polycystic ovary syndrome	0.000257	0.00259	CbGeAlD
Dinoprostone—SLCO2B1—endocrine gland—polycystic ovary syndrome	0.000251	0.00253	CbGeAlD
Dinoprostone—CYP19A1—female gonad—polycystic ovary syndrome	0.000243	0.00245	CbGeAlD
Dinoprostone—SLC22A1—endocrine gland—polycystic ovary syndrome	0.00024	0.00242	CbGeAlD
Dinoprostone—ABCC4—female gonad—polycystic ovary syndrome	0.000239	0.00241	CbGeAlD
Dinoprostone—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.000231	0.00233	CbGeAlD
Dinoprostone—CYP19A1—endocrine gland—polycystic ovary syndrome	0.000226	0.00227	CbGeAlD
Dinoprostone—ABCC4—endocrine gland—polycystic ovary syndrome	0.000223	0.00224	CbGeAlD
Dinoprostone—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000151	0.00152	CbGeAlD
Dinoprostone—Chest discomfort—Metformin—polycystic ovary syndrome	1.18e-05	0.0908	CcSEcCtD
Dinoprostone—PTGIR—Signaling Pathways—PRL—polycystic ovary syndrome	8.41e-06	6.21e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—SULT2A1—polycystic ovary syndrome	8.4e-06	6.2e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	8.28e-06	6.11e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.28e-06	6.11e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	8.25e-06	6.08e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—LHB—polycystic ovary syndrome	8.24e-06	6.08e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.2e-06	6.05e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	8.17e-06	6.03e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—TH—polycystic ovary syndrome	8.16e-06	6.02e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.15e-06	6.01e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—RRM2—polycystic ovary syndrome	8.13e-06	6e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	8.11e-06	5.98e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.11e-06	5.98e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.11e-06	5.98e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IRS2—polycystic ovary syndrome	8.1e-06	5.97e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	8.09e-06	5.97e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—HSD3B2—polycystic ovary syndrome	8.06e-06	5.94e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—SERPINE1—polycystic ovary syndrome	8e-06	5.9e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.98e-06	5.89e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.98e-06	5.89e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—SLC2A4—polycystic ovary syndrome	7.94e-06	5.86e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—LEP—polycystic ovary syndrome	7.92e-06	5.85e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—YAP1—polycystic ovary syndrome	7.84e-06	5.78e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKR1C1—polycystic ovary syndrome	7.8e-06	5.76e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	7.75e-06	5.72e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	7.72e-06	5.7e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IRS1—polycystic ovary syndrome	7.66e-06	5.65e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MTHFR—polycystic ovary syndrome	7.65e-06	5.64e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.62e-06	5.62e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GNAS—polycystic ovary syndrome	7.61e-06	5.61e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	7.59e-06	5.6e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GNAS—polycystic ovary syndrome	7.56e-06	5.58e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	7.55e-06	5.57e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NAMPT—polycystic ovary syndrome	7.53e-06	5.56e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.49e-06	5.52e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CYP19A1—polycystic ovary syndrome	7.47e-06	5.51e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP11A1—polycystic ovary syndrome	7.44e-06	5.49e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GNAS—polycystic ovary syndrome	7.4e-06	5.46e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GNAS—polycystic ovary syndrome	7.4e-06	5.46e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	7.4e-06	5.46e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.39e-06	5.45e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	7.38e-06	5.45e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—POMC—polycystic ovary syndrome	7.38e-06	5.44e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	7.35e-06	5.42e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—INS—polycystic ovary syndrome	7.33e-06	5.41e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IRS2—polycystic ovary syndrome	7.28e-06	5.37e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—NCOR1—polycystic ovary syndrome	7.25e-06	5.35e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	7.23e-06	5.33e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.2e-06	5.31e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—SULT2A1—polycystic ovary syndrome	7.18e-06	5.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	7.15e-06	5.28e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IGF1—polycystic ovary syndrome	7.09e-06	5.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	7.09e-06	5.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	7.09e-06	5.23e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT2—polycystic ovary syndrome	7.09e-06	5.23e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	7.09e-06	5.23e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IRS1—polycystic ovary syndrome	7.07e-06	5.21e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NRG1—polycystic ovary syndrome	7.07e-06	5.21e-05	CbGpPWpGaD
Dinoprostone—Dehydration—Metformin—polycystic ovary syndrome	7.05e-06	0.0542	CcSEcCtD
Dinoprostone—PTGER1—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.05e-06	5.2e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.05e-06	5.2e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	7.04e-06	5.19e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.02e-06	5.18e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	7e-06	5.17e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—RRM2—polycystic ovary syndrome	6.96e-06	5.13e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NRG1—polycystic ovary syndrome	6.92e-06	5.1e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NRG1—polycystic ovary syndrome	6.92e-06	5.1e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP17A1—polycystic ovary syndrome	6.92e-06	5.1e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	6.88e-06	5.08e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—CYP1A1—polycystic ovary syndrome	6.87e-06	5.07e-05	CbGpPWpGaD
Dinoprostone—Cramp muscle—Metformin—polycystic ovary syndrome	6.83e-06	0.0525	CcSEcCtD
Dinoprostone—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	6.81e-06	5.02e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—POMC—polycystic ovary syndrome	6.81e-06	5.02e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—INS—polycystic ovary syndrome	6.77e-06	4.99e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.77e-06	4.99e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.74e-06	4.97e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	6.72e-06	4.96e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—YAP1—polycystic ovary syndrome	6.7e-06	4.95e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.67e-06	4.92e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GNAS—polycystic ovary syndrome	6.66e-06	4.92e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	6.66e-06	4.92e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—IL6—polycystic ovary syndrome	6.61e-06	4.87e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	6.59e-06	4.86e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	6.58e-06	4.85e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	6.57e-06	4.85e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IGF1—polycystic ovary syndrome	6.55e-06	4.83e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT2—polycystic ovary syndrome	6.54e-06	4.83e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	6.44e-06	4.75e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NAMPT—polycystic ovary syndrome	6.44e-06	4.75e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—MTHFR—polycystic ovary syndrome	6.41e-06	4.73e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.4e-06	4.72e-05	CbGpPWpGaD
Dinoprostone—Sweating increased—Metformin—polycystic ovary syndrome	6.39e-06	0.0491	CcSEcCtD
Dinoprostone—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	6.37e-06	4.7e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP11A1—polycystic ovary syndrome	6.36e-06	4.69e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IRS1—polycystic ovary syndrome	6.35e-06	4.69e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—NCOR1—polycystic ovary syndrome	6.35e-06	4.68e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	6.35e-06	4.68e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.32e-06	4.66e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	6.25e-06	4.61e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.22e-06	4.59e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	6.14e-06	4.53e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	6.13e-06	4.52e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—INS—polycystic ovary syndrome	6.08e-06	4.49e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IRS2—polycystic ovary syndrome	6.05e-06	4.47e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CYP1A1—polycystic ovary syndrome	6.02e-06	4.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.02e-06	4.44e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKR1C3—polycystic ovary syndrome	6.01e-06	4.43e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—TH—polycystic ovary syndrome	5.98e-06	4.41e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	5.94e-06	4.38e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IRS2—polycystic ovary syndrome	5.93e-06	4.37e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.93e-06	4.37e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—LEP—polycystic ovary syndrome	5.92e-06	4.37e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP17A1—polycystic ovary syndrome	5.91e-06	4.36e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	5.9e-06	4.35e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT2—polycystic ovary syndrome	5.88e-06	4.34e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	5.83e-06	4.3e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5.82e-06	4.29e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—LEP—polycystic ovary syndrome	5.8e-06	4.28e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—LEP—polycystic ovary syndrome	5.8e-06	4.28e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	5.73e-06	4.22e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	5.71e-06	4.21e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.64e-06	4.16e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—MTHFR—polycystic ovary syndrome	5.61e-06	4.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	5.61e-06	4.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	5.61e-06	4.14e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SERPINE1—polycystic ovary syndrome	5.59e-06	4.12e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	5.5e-06	4.06e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VEGFA—polycystic ovary syndrome	5.5e-06	4.06e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	5.5e-06	4.06e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP19A1—polycystic ovary syndrome	5.47e-06	4.04e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	5.43e-06	4.01e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL6—polycystic ovary syndrome	5.43e-06	4e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	5.42e-06	4e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—TH—polycystic ovary syndrome	5.41e-06	3.99e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	5.39e-06	3.98e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.31e-06	3.91e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IRS1—polycystic ovary syndrome	5.29e-06	3.9e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	5.26e-06	3.88e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PPARG—polycystic ovary syndrome	5.2e-06	3.83e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IRS1—polycystic ovary syndrome	5.17e-06	3.82e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.17e-06	3.82e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	5.13e-06	3.79e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—POMC—polycystic ovary syndrome	5.12e-06	3.78e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—TH—polycystic ovary syndrome	5.12e-06	3.77e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—INS—polycystic ovary syndrome	5.1e-06	3.76e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—POMC—polycystic ovary syndrome	5.09e-06	3.75e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—INS—polycystic ovary syndrome	5.06e-06	3.73e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	5.05e-06	3.73e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL6—polycystic ovary syndrome	5.01e-06	3.69e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—POMC—polycystic ovary syndrome	4.98e-06	3.68e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—POMC—polycystic ovary syndrome	4.98e-06	3.68e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—SLC2A4—polycystic ovary syndrome	4.98e-06	3.67e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—INS—polycystic ovary syndrome	4.95e-06	3.65e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—INS—polycystic ovary syndrome	4.95e-06	3.65e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IGF1—polycystic ovary syndrome	4.9e-06	3.61e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT2—polycystic ovary syndrome	4.89e-06	3.61e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	4.89e-06	3.6e-05	CbGpPWpGaD
Dinoprostone—Flushing—Metformin—polycystic ovary syndrome	4.87e-06	0.0374	CcSEcCtD
Dinoprostone—PTGIR—Signaling Pathways—IGF1—polycystic ovary syndrome	4.79e-06	3.54e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.79e-06	3.54e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT2—polycystic ovary syndrome	4.79e-06	3.53e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.79e-06	3.53e-05	CbGpPWpGaD
Dinoprostone—Angiopathy—Metformin—polycystic ovary syndrome	4.76e-06	0.0366	CcSEcCtD
Dinoprostone—Immune system disorder—Metformin—polycystic ovary syndrome	4.74e-06	0.0364	CcSEcCtD
Dinoprostone—Chills—Metformin—polycystic ovary syndrome	4.71e-06	0.0362	CcSEcCtD
Dinoprostone—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	4.7e-06	3.47e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—TH—polycystic ovary syndrome	4.69e-06	3.46e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP19A1—polycystic ovary syndrome	4.68e-06	3.45e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.65e-06	3.43e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.65e-06	3.43e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.63e-06	3.42e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	4.56e-06	3.36e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.55e-06	3.36e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.55e-06	3.36e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PPARG—polycystic ovary syndrome	4.55e-06	3.36e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—POMC—polycystic ovary syndrome	4.49e-06	3.31e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—INS—polycystic ovary syndrome	4.46e-06	3.29e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	4.45e-06	3.29e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	4.42e-06	3.26e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.41e-06	3.25e-05	CbGpPWpGaD
Dinoprostone—Muscle spasms—Metformin—polycystic ovary syndrome	4.39e-06	0.0338	CcSEcCtD
Dinoprostone—SLC22A1—Metabolism—TH—polycystic ovary syndrome	4.37e-06	3.22e-05	CbGpPWpGaD
Dinoprostone—Vision blurred—Metformin—polycystic ovary syndrome	4.3e-06	0.0331	CcSEcCtD
Dinoprostone—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	4.29e-06	3.16e-05	CbGpPWpGaD
Dinoprostone—Tremor—Metformin—polycystic ovary syndrome	4.28e-06	0.0329	CcSEcCtD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.28e-06	3.15e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	4.25e-06	3.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	4.25e-06	3.13e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	4.21e-06	3.1e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.2e-06	3.1e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GNAS—polycystic ovary syndrome	4.18e-06	3.08e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.11e-06	3.03e-05	CbGpPWpGaD
Dinoprostone—Syncope—Metformin—polycystic ovary syndrome	4.1e-06	0.0315	CcSEcCtD
Dinoprostone—Loss of consciousness—Metformin—polycystic ovary syndrome	4.01e-06	0.0309	CcSEcCtD
Dinoprostone—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	4e-06	2.95e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	3.99e-06	2.94e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NCOR1—polycystic ovary syndrome	3.98e-06	2.94e-05	CbGpPWpGaD
Dinoprostone—Hypertension—Metformin—polycystic ovary syndrome	3.94e-06	0.0303	CcSEcCtD
Dinoprostone—PTGER4—Signaling Pathways—IL6—polycystic ovary syndrome	3.9e-06	2.88e-05	CbGpPWpGaD
Dinoprostone—Chest pain—Metformin—polycystic ovary syndrome	3.89e-06	0.0299	CcSEcCtD
Dinoprostone—Myalgia—Metformin—polycystic ovary syndrome	3.89e-06	0.0299	CcSEcCtD
Dinoprostone—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	3.83e-06	2.82e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	3.79e-06	2.79e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP1A1—polycystic ovary syndrome	3.77e-06	2.78e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—polycystic ovary syndrome	3.74e-06	2.76e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	3.72e-06	2.74e-05	CbGpPWpGaD
Dinoprostone—Shock—Metformin—polycystic ovary syndrome	3.67e-06	0.0282	CcSEcCtD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—polycystic ovary syndrome	3.66e-06	2.7e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.66e-06	2.7e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	3.65e-06	2.69e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	3.61e-06	2.67e-05	CbGpPWpGaD
Dinoprostone—Hyperhidrosis—Metformin—polycystic ovary syndrome	3.6e-06	0.0277	CcSEcCtD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.57e-06	2.63e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	3.57e-06	2.63e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—polycystic ovary syndrome	3.52e-06	2.59e-05	CbGpPWpGaD
Dinoprostone—Hypotension—Metformin—polycystic ovary syndrome	3.48e-06	0.0268	CcSEcCtD
Dinoprostone—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.46e-06	2.55e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	3.4e-06	2.51e-05	CbGpPWpGaD
Dinoprostone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	3.4e-06	0.0261	CcSEcCtD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.39e-06	2.5e-05	CbGpPWpGaD
Dinoprostone—Paraesthesia—Metformin—polycystic ovary syndrome	3.35e-06	0.0257	CcSEcCtD
Dinoprostone—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	3.33e-06	2.46e-05	CbGpPWpGaD
Dinoprostone—Dyspnoea—Metformin—polycystic ovary syndrome	3.32e-06	0.0255	CcSEcCtD
Dinoprostone—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	3.29e-06	2.43e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	3.29e-06	2.43e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	3.27e-06	2.41e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	3.22e-06	2.38e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	3.22e-06	2.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	3.22e-06	2.38e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—polycystic ovary syndrome	3.21e-06	2.36e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.2e-06	2.36e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.13e-06	2.31e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.13e-06	2.31e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	3.12e-06	2.3e-05	CbGpPWpGaD
Dinoprostone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	3.05e-06	0.0234	CcSEcCtD
Dinoprostone—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	3.01e-06	2.22e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	3e-06	2.22e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	2.97e-06	2.19e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—polycystic ovary syndrome	2.96e-06	2.18e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—INS—polycystic ovary syndrome	2.96e-06	2.18e-05	CbGpPWpGaD
Dinoprostone—Abdominal pain—Metformin—polycystic ovary syndrome	2.95e-06	0.0227	CcSEcCtD
Dinoprostone—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.87e-06	2.12e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARG—polycystic ovary syndrome	2.85e-06	2.1e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—POMC—polycystic ovary syndrome	2.81e-06	2.07e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—INS—polycystic ovary syndrome	2.8e-06	2.06e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	2.78e-06	2.05e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	2.68e-06	1.98e-05	CbGpPWpGaD
Dinoprostone—Asthenia—Metformin—polycystic ovary syndrome	2.67e-06	0.0206	CcSEcCtD
Dinoprostone—ABCC5—Disease—IL6—polycystic ovary syndrome	2.66e-06	1.96e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	2.61e-06	1.93e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	2.58e-06	1.9e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	2.57e-06	1.9e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—INS—polycystic ovary syndrome	2.56e-06	1.89e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.56e-06	1.89e-05	CbGpPWpGaD
Dinoprostone—Diarrhoea—Metformin—polycystic ovary syndrome	2.55e-06	0.0196	CcSEcCtD
Dinoprostone—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	2.54e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.52e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—Dizziness—Metformin—polycystic ovary syndrome	2.47e-06	0.0189	CcSEcCtD
Dinoprostone—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	2.44e-06	1.8e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	2.4e-06	1.77e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	2.4e-06	1.77e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—INS—polycystic ovary syndrome	2.39e-06	1.76e-05	CbGpPWpGaD
Dinoprostone—Vomiting—Metformin—polycystic ovary syndrome	2.37e-06	0.0182	CcSEcCtD
Dinoprostone—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	2.36e-06	1.74e-05	CbGpPWpGaD
Dinoprostone—Rash—Metformin—polycystic ovary syndrome	2.35e-06	0.0181	CcSEcCtD
Dinoprostone—Dermatitis—Metformin—polycystic ovary syndrome	2.35e-06	0.018	CcSEcCtD
Dinoprostone—Headache—Metformin—polycystic ovary syndrome	2.34e-06	0.018	CcSEcCtD
Dinoprostone—Nausea—Metformin—polycystic ovary syndrome	2.21e-06	0.017	CcSEcCtD
Dinoprostone—PTGFR—Signaling Pathways—IL6—polycystic ovary syndrome	2.21e-06	1.63e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—polycystic ovary syndrome	2.16e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—polycystic ovary syndrome	2.16e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TH—polycystic ovary syndrome	2.04e-06	1.51e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.99e-06	1.47e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.87e-06	1.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.67e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.59e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.51e-06	1.11e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.41e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.14e-06	8.41e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.12e-06	8.29e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.12e-06	8.25e-06	CbGpPWpGaD
